Aimei Health Technology received notice from Nasdaq on May 19, 2026 that it failed to timely file its Q1 2026 10-Q, putting it out of compliance with listing rules. The company has 60 calendar days to file the report or submit a compliance plan, or face potential delisting from Nasdaq.